Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 83 results for "lacosamide"

Human medicines European public assessment report (EPAR): Vi...

This is a summary of the European public assessment report (EPAR) for Vimpat. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ... European Medicines Agency, 1 week ago

Market Research Report on Global and Chinese Lacosamide Industry, 2009-2019

is a professional and in-depth market survey on Global and Chinese Lacosamide industry. The report firstly reviews the basic information of Lacosamide including its classification, application and manufacturing technology; The report then explores ...
 Individual.com1 week ago
Pharmaceutical Technology

Daiichi and UCB Biopharma partner to introduce epilepsy treatment Lacosamide in Japan

Japan-based Daiichi Sankyo has signed an agreement with UCB Biopharma to jointly commercialise Lacosamide for the treatment of patients with epilepsy in Japan. As part of the deal, UCB will manufacture and supply the product for commercialisation ...
 Pharmaceutical Technology1 month ago Daiichi Sankyo and UCB partner to commercialize epilepsy drug in Japan  Individual.com1 month ago Daiichi Sankyo, UCB to jointly commercialise lacosamide for epilepsy patients in Japan  PharmaBiz1 month ago Daiichi Sankyo : UCB to jointly commercialize epilepsy drug Lacosamide in Japan  4 Traders1 month ago
[x]  

BRIEF-UCB announces partnership with Daiichi Sankyo in Japan

Nov 28 (Reuters) - UCB SA : * Announces partnership with Daiichi Sankyo for co-commercialization of Lacosamide in Japan * Says it will manufacture and supply product for commercialization, Daiichi Sankyo will manage distribution and book sales ...
 Reuters UK1 month ago

UCB reinforces its leadership in epilepsy at the 2014 Annual Meeting of the American Epilepsy Society (AES)

From the Wires - 24 UCB-sponsored presentations including new data on VIMPATĀ® (lacosamide) Dec. 3, 2014 01:00 AM BRUSSELS , Dec. 3,2014 /PRNewswire/ -- UCB, a global biopharmaceutical company with a focus on epilepsy treatment and ...
 Sys-Con India1 month ago
[x]  

UCB and Daiichi Sankyo partner to bring Lacosamide to people living with epilepsy in Japan

 Noodls1 month ago DAIICHI SANKYO : UCB and Daiichi Sankyo partner to bring Lacosamide to people living with epilepsy in Japan  4 Traders1 month ago

Exalief (Eslicarbazepine Acetate) Soon to be Available in Russia as a Once Daily Adjunctive Treatment of Partial Onset Seizures in Adults

/PRNewswire/ -- PRESS RELEASE FOR EU MEDIA ONLY: NOT FOR SWISS/U.S. JOURNALISTS Novel, anti-epilepsy treatment Exalief(R) will soon be available in Russia. (Exalief is also marketed under the trade name Zebinix in Europe). Once-daily ...
 Individual.com6 days ago
Pharma Letter

UCB appoints Jean-Christophe Tellier as chief executive

Belgian drugmaker UCB has replaced chief executive Roch Doliveux with Jean-Christophe Tellier. Mr Tellier will also be chairman of the executive committee and a member of the board of directors. His predecessor, Roch Doliveux, stepped down on ...
 Pharma Letter1 week ago

Abbott India, Sun Pharma, Lupin, GlaxoSmithKline & Cipla in tight contest at Pharmaleaders 2014 Awards in top categories

The race to the coveted & credible award for India's Most Admired & Powerful Brand, Corporate Practice, Investor Relations intensifies at 7th Annual Pharmaceutical Leadership Summit & Awards 2014 with a big voting in top four categories to select ...
 PharmiWeb1 month ago

Epilepsy Dominant at Lebanese Society of Neurology's 6th International Congress as Novel Treatment Option Unveiled

: Epilepsy featured prominently at the just-concluded 6 th Lebanese Society of Neurology International Congress, with the introduction of lacosamide a drug commercialized as VIMPAT that is available in tablets, oral solution or injections as an ...
 Executive Business Magazine1 month ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less